000739 Apeloa Pharmaceutical

Watchlist

16.27
-0.37-2.22%

Market Closed Dec 13 15:00 CST

19.02BMarket Cap17.72P/E (TTM)

About Apeloa Pharmaceutical Company

The company was founded in 1989. It is a pharmaceutical industry development platform for the famous private enterprise Hengdian Group, and a company listed on the main board of the Shenzhen Stock Exchange. The company's API business has accumulated a large number of technical achievements and human resources, and has taken the lead and continues to invest heavily in environmental protection management, technological transformation, and product development in the Chinese API industry. It has formed a strong competitive advantage in terms of cost, quality, EHS and technology, and has become a leading domestic specialty ingredient enterprise. The main business covers R&D, production and sales of API intermediates, innovative drug R&D and production services (CDMO), formulations, etc., as well as import and export trade business. The main products include levetiracetam tablets, ufenmex capsules, cefixime series, amoxicillin and clavulanate potassium capsules, levofloxacin tablets, metoprolol succinate sustained-release tablets, fucloxacillin sodium for injection, and ceftazidime for injections (cooperation). Ranked 38th in the “2022 China Pharmaceutical Industry Top 100 Enterprises”. It was awarded the National Development and Reform Commission's “Advanced Manufacturing and Modern Service Industry Integrated Development Pilot Project” and the honorary title of “Green Factory” at the national level; won the “China Top 100 High-Growth Enterprise Award”; selected as an “Eagle Action” nurturing enterprise in Zhejiang Province; “2023 Top 20 Chinese Pharmaceutical CDMO Companies”, “2023 Industry Benchmarking Award Best Industrial Enterprise and Best Pharmaceutical Industry”, “20th place in the 2022 China Chemical Pharmaceutical Enterprise Top 100 List and 12th Chinese CXO Enterprise TOP20”; and won the “2023 National Intellectual Property Demonstration Enterprise” Many honors include “2023 National Excellent Case of Enterprise Integrity Construction Practice”, “Zhejiang Science and Technology Little Giant Enterprise”, and “Second Batch of Zhejiang Intellectual Property Demonstration Enterprises”.

Company Profile

Short Name-A普洛药业

Symbol-A000739

Company NameApeloa Pharmaceutical Co., Ltd.

Listing DateMay 9, 1997

Issue Price5.70

Shares Offered30.00M share(s)

FoundedMay 6, 1997

Listed ExchangeSZ Stock Exchange

Legal Representativefangmeng zhu

General Managerchun he

Secretaryyuwang zhou

Accounting FirmHexin Certified Public Accountants (Special General Partnership)

Securities Representativejian guan

Legal CounselBeijing Kangda Law Firm

Employees745

Phone0579-86557527

Office AddressNo. 399 Jiangnan Road, Hengdian, Dongyang City, Zhejiang Province

Zip Code322118

Registered AddressNo. 399 Jiangnan Road, Hengdian, Dongyang City, Jinhua City, Zhejiang Province

Fax0579-86558122

Email000739@apeloa.com

Websitehttp://www.apeloa.com

Business License370200018046069

BusinessPharmaceutical industry investment, network investment, equity investment management, research, development and transfer of biopharmaceutical technology, domestic trade; import and export business.

Company Executives

Name
Position
Salary

fangmeng zhu
Chairman, Directors, Nomination Committee Members, Chairman of the Strategy Committee, Member of the Remuneration and Assessment Committee, Audit Committee Member
2.40M

xinliang xu
Vice Chairman, Directors, Nomination Committee Members, Strategy Committee Member, Member of the Remuneration and Assessment Committee, Audit Committee Member
1.44M

wencai xu
Directors, Strategy Committee Member
--

tiangao hu
Directors, Strategy Committee Member
--

weiguang pan
Independent Directors, Audit Committee Member, Chairman of the Nomination Committee, Member of the Remuneration and Assessment Committee, Strategy Committee Member
88.20K

juanping qian
Independent Directors, Member of the Remuneration and Assessment Committee, Chairman of the Audit Committee, Strategy Committee Member, Nomination Committee Members
88.20K

ling chen
Independent Directors, Nomination Committee Members, Strategy Committee Member, Chairman of the Remuneration and Assessment Committee, Audit Committee Member
88.20K